# A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic Respiratory Failure

> clinical trial · VERIFIED · 2026-06-26

Status: RECRUITING · Sponsor: MiNK Therapeutics · Condition: Pneumonia

- Company: MiNK Therapeutics
- Sector: immunotherapy
- Primary source: https://clinicaltrials.gov/study/NCT07615010

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.